Editor selected abstracts and commentaries
- Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder; Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB
- NeoTract Announces Data from Large Real-World Study of UroLift®System, Confirming Positive Results for Company’s Treatment for Enlarged Prostate
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- Certain BCG-reactive responses are associated with bladder cancer prognosis.
- Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.
Searchable data base of currently enrolling clinical trials
Recent data from conferences worldwide
- EAU 2018: The Impact of Surgical Strategy in Robot-Assisted Partial Nephrectomy: Should we Treat Anterior Tumors with Transperitoneal Access and Posterior Tumors with Retroperitoneal Access?
- EAU 2018: Perioperative Outcomes of Aspirin Use in Partial Nephrectomy
- EAU 2018: Quality of Life of Spouses Living with Men Undergoing Androgen Deprivation Therapy for Prostate Cancer
Print publications focusing on urological cancer treatments through original commentary & articles